FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2594414463> ?p ?o ?g. }

• W2594414463 abstract "Abstract Autologous stem cell transplantation is an efficacy therapy for limphoproliferative disease. However a concern with the procedure is the potential of malignant cells to reinfuse with stem-cell graft. In the past five year, investigators have used rituximab to purge malignant cells in vivo without any manipulation in vitro. From April 2003 to June 2008 we have treated with Autologous stem cell transplantation, purged in vivo with monoclonal antibodies, 24 patients (8 F; 16 M median age: 55 years) with limphoproliferative diseases to poor prognosis (2 Burkitt lymphoma; 3 Burkitt like lymphoma; 4 mantle cells; 3 CLL; 3 NHL-T cells (1 peripheral and 2 lymphoblastic); 2 follicular and 7 large cells) and we have evaluated the results and the feasibility. In all patients, the purged in vivo, has been effected administering a dose of monoclonal antibodies (anti CD20 in B-NHL and anti CD52 in CLL and T-NHL) before the harvest and after the infusion of the stem-cells. To the transplantation 10 patients were in CR (2 Burkitt lymphoma; 3 Burkitt like lymphoma; 2 large cells; 2 NHL-T lymphoblastic and 1 mantle cells) 9 in PR (1 CLL; 3 mantle cells; 2 follicular and 4 large cells lymphoma) and 5 in resistant disease (2 CLL; 2 large cells and 1 NHL peripheral T cells). All patients have harvest (median CD34:4 ×106/Kg) and median minimal residual disease in the harvest has been &lt; to 2%. All the patients have been conditioned with BEAM and the graft are documented in 22/24 patients (2 patients are dead to the day +4 and +10 for gastric haemorrhage and septic shock respectively) with neutrophils&gt; 1000 in media to day + 11 (range 10–19 days). After transplantation 20/22 patients were in CR, a day +60 the MMR in bone marrow was &lt;0, 5% (range 0–0, 3%). With a median follow-up of 18 months after transplantation (range 2–64) 12/22 (54,5%) patients are in CR (8 patients have relapsed: 1 burkitt lymphoma (is relapsed extra-nodular at months +3 and died for disease a months + 5 after transplantation); 1 mantle cells (month +11); 2 follicular (months +21; +23); 1 large cells (month +14);1 NHL-peripheral T-cells (month +13); 1 NHL-T lymphoblastic (month +7) and 1 CLL (month +53). Two patients are results to be resistant to the treatment (2 large cells B lymphoma). Two patients (1 large cells and 1 CLL) are died in remission at months +3 and + 7 for CMV reactivation and interstitial pneumonia respectively. The EFS and OS projected at 50 months are of the 50% and 63% respectively. In conclusion the purging in vivo with antibodies monoclonal, effected during the harvest that immediately after the infusion of the stem-cells, allows to get besides a graft with least residual disease in this cohort (patients with poor prognosis) and the preliminary results they are interesting. The principal problem in these patients have been primarily the infectious and gastro-intestinal complications, these has been correlated to patients over treated and in disease. These data suggest treating in first line, with transplantation of stem-cells purged in vivo with monoclonal antibodies to eradicate the MRD, patients to poor prognosis or with chronic limphoproliferative disease." @default.
• W2594414463 created "2017-03-16" @default.
• W2594414463 creator A5000602610 @default.
• W2594414463 creator A5039744091 @default.
• W2594414463 creator A5041347112 @default.
• W2594414463 creator A5044869604 @default.
• W2594414463 creator A5054001250 @default.
• W2594414463 creator A5083031946 @default.
• W2594414463 creator A5084262338 @default.
• W2594414463 creator A5090939110 @default.
• W2594414463 date "2008-11-16" @default.
• W2594414463 modified "2023-10-01" @default.
• W2594414463 title "Purging in Vivo and Auto-Transplantation in Patients with Poor Prognosis Lymphoproliferative Disease" @default.
• W2594414463 doi "https://doi.org/10.1182/blood.v112.11.4446.4446" @default.
• W2594414463 hasPublicationYear "2008" @default.
• W2594414463 type Work @default.
• W2594414463 sameAs 2594414463 @default.
• W2594414463 citedByCount "0" @default.
• W2594414463 crossrefType "journal-article" @default.
• W2594414463 hasAuthorship W2594414463A5000602610 @default.
• W2594414463 hasAuthorship W2594414463A5039744091 @default.
• W2594414463 hasAuthorship W2594414463A5041347112 @default.
• W2594414463 hasAuthorship W2594414463A5044869604 @default.
• W2594414463 hasAuthorship W2594414463A5054001250 @default.
• W2594414463 hasAuthorship W2594414463A5083031946 @default.
• W2594414463 hasAuthorship W2594414463A5084262338 @default.
• W2594414463 hasAuthorship W2594414463A5090939110 @default.
• W2594414463 hasConcept C126322002 @default.
• W2594414463 hasConcept C142724271 @default.
• W2594414463 hasConcept C18031839 @default.
• W2594414463 hasConcept C203014093 @default.
• W2594414463 hasConcept C2777058707 @default.
• W2594414463 hasConcept C2777525834 @default.
• W2594414463 hasConcept C2779050716 @default.
• W2594414463 hasConcept C2779338263 @default.
• W2594414463 hasConcept C2780653079 @default.
• W2594414463 hasConcept C28328180 @default.
• W2594414463 hasConcept C2911091166 @default.
• W2594414463 hasConcept C502942594 @default.
• W2594414463 hasConcept C54355233 @default.
• W2594414463 hasConcept C71924100 @default.
• W2594414463 hasConcept C86803240 @default.
• W2594414463 hasConcept C90924648 @default.
• W2594414463 hasConceptScore W2594414463C126322002 @default.
• W2594414463 hasConceptScore W2594414463C142724271 @default.
• W2594414463 hasConceptScore W2594414463C18031839 @default.
• W2594414463 hasConceptScore W2594414463C203014093 @default.
• W2594414463 hasConceptScore W2594414463C2777058707 @default.
• W2594414463 hasConceptScore W2594414463C2777525834 @default.
• W2594414463 hasConceptScore W2594414463C2779050716 @default.
• W2594414463 hasConceptScore W2594414463C2779338263 @default.
• W2594414463 hasConceptScore W2594414463C2780653079 @default.
• W2594414463 hasConceptScore W2594414463C28328180 @default.
• W2594414463 hasConceptScore W2594414463C2911091166 @default.
• W2594414463 hasConceptScore W2594414463C502942594 @default.
• W2594414463 hasConceptScore W2594414463C54355233 @default.
• W2594414463 hasConceptScore W2594414463C71924100 @default.
• W2594414463 hasConceptScore W2594414463C86803240 @default.
• W2594414463 hasConceptScore W2594414463C90924648 @default.
• W2594414463 hasLocation W25944144631 @default.
• W2594414463 hasOpenAccess W2594414463 @default.
• W2594414463 hasPrimaryLocation W25944144631 @default.
• W2594414463 hasRelatedWork W1974181247 @default.
• W2594414463 hasRelatedWork W1977317891 @default.
• W2594414463 hasRelatedWork W2015978579 @default.
• W2594414463 hasRelatedWork W2019173212 @default.
• W2594414463 hasRelatedWork W2032832875 @default.
• W2594414463 hasRelatedWork W2035521172 @default.
• W2594414463 hasRelatedWork W2101819692 @default.
• W2594414463 hasRelatedWork W2106168795 @default.
• W2594414463 hasRelatedWork W2113249727 @default.
• W2594414463 hasRelatedWork W2402566042 @default.
• W2594414463 hasRelatedWork W2503013136 @default.
• W2594414463 hasRelatedWork W2754037371 @default.
• W2594414463 hasRelatedWork W2896630375 @default.
• W2594414463 hasRelatedWork W2901736165 @default.
• W2594414463 hasRelatedWork W2922061986 @default.
• W2594414463 hasRelatedWork W2984381018 @default.
• W2594414463 hasRelatedWork W3030850943 @default.
• W2594414463 hasRelatedWork W3033953548 @default.
• W2594414463 hasRelatedWork W3081959507 @default.
• W2594414463 hasRelatedWork W2942877147 @default.
• W2594414463 isParatext "false" @default.
• W2594414463 isRetracted "false" @default.
• W2594414463 magId "2594414463" @default.
• W2594414463 workType "article" @default.